"Blessing Health System is an integrated health system consisting of, two physician groups, an accredited college of nursing and health sciences, a network of medical specialty businesses and a charitable foundation."

During the past decade, Blessing Corporate Services conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Blessing Corporate Services" are "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Blessing Corporate Services" in a lesser frequency.

Most popular intervention types in "Blessing Corporate Services" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enobosarm" (1 trials), "Exemestane" (1 trials), "Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator" (1 trials) and "Sabizabulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blessing Corporate Services" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Blessing Corporate Services". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Blessing Corporate Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blessing Corporate Services, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".